Provided by Tiger Trade Technology Pte. Ltd.

Ashland

69.02
-0.5000-0.72%
Volume:15.27K
Turnover:1.05M
Market Cap:3.16B
PE:60.06
High:69.10
Open:68.97
Low:68.97
Close:69.52
52wk High:78.25
52wk Low:47.12
Shares:45.76M
Float Shares:37.72M
Volume Ratio:1.04
T/O Rate:0.04%
Dividend:1.67
Dividend Rate:2.41%
EPS(TTM):1.15
EPS(LYR):-18.3696
ROE:3.99%
ROA:2.43%
PB:1.69
PE(LYR):-3.76

Loading ...

Ashland Outlook FY Adjusted Ebitda USD 385-400 Million VS. Ibes Estimate USD 385.1 Million

THOMSON REUTERS
·
Jul 29

Ashland Q3 Adjusted EPS USD 1.02 VS. Ibes Estimate USD 0.99

THOMSON REUTERS
·
Jul 29

Ashland - Revises Fy2026 Adj EPS Ex Intangibles Amortization to Low-to-Mid Single-Digit Growth

THOMSON REUTERS
·
Jul 29

Ashland Reports Third Quarter 2026 Results and Reaffirms Full-Year Sales & Adjusted Ebitda Outlook

THOMSON REUTERS
·
Jul 29

Press Release: Ashland Reports Third Quarter 2026 Results and Reaffirms Full-year Sales & Adjusted Ebitda Outlook

Dow Jones
·
Jul 29

Ashland Appoints Peter Thomas, Allen Spizzo as Independent Directors Under Ancora Deal

Reuters
·
Jul 29

Ashland - Ancora Agrees to Standstill and Voting Commitments Under Cooperation Agreement

THOMSON REUTERS
·
Jul 29

Ashland - Board Temporarily Expands to 11 Members, to Reduce to 10 in 2027

THOMSON REUTERS
·
Jul 29

Ashland Inc - Effective Immediately, Board Will Appoint Peter Thomas and Allen Spizzo as Independent Members

THOMSON REUTERS
·
Jul 29

Ashland Announces Appointment of Two New Directors as Part of Cooperation Agreement with Stockholder Ancora

THOMSON REUTERS
·
Jul 29

Ashland announces appointment of two new directors as part of Cooperation Agreement with stockholder Ancora

GlobeNewswire
·
Jul 29

Market Chatter: Ashland Moves Toward Agreement With Activist Investor Ancora

MT Newswires Live
·
Jul 29

Chemical-Maker Ashland is Said to Near Settlement with Ancora - Bloomberg News

THOMSON REUTERS
·
Jul 29

Ashland near settlement with activist Ancora, Bloomberg reports

TIPRANKS
·
Jul 29

Cullinan Therapeutics Announces Positive End-of-Phase 1 Meeting with FDA for CLN-049 and Advances Program to a Potentially Registrational Phase 2 Study in AML

GlobeNewswire
·
Jul 28

Analysts Offer Insights on Materials Companies: Ashland (ASH) and Alpek SAB de CV (OtherALPKF)

TIPRANKS
·
Jul 28

Wolfe Research boosts Ashland price target, cites activist pressures

TIPRANKS
·
Jul 28

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 27

Ashland (ASH) Stock May Be 27% Undervalued On Cash Flow Strength

Simply Wall St.
·
Jul 24

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 24